EUVIMEDEUVIMED entdecken
EditorialOpen Access

Editorial: Upadacitinib in Perianal Crohn's Disease. Authors' Reply

Nicolas Richard, Mathurin Fumery

Alimentary Pharmacology & Therapeutics · 2026-08 · 64 (4) · 546-547

DOI: 10.1111/apt.70817 ↗

Kurz gefasst

Editorial in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 20.06.2026. Verfasst von Nicolas Richard und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Univ Rouen Normandie, INSERM, ADEN UMR1073, "Nutrition, Inflammation and Microbiota-Gut-Brain Axis", CHU Rouen, Rouen…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Gastroenterology, Univ Rouen Normandie, INSERM, ADEN UMR1073, "Nutrition, Inflammation and Microbiota-Gut-Brain Axis", CHU Rouen, Rouen, France.
  • Department of Gastroenterology, Amiens University Hospital and PeriTox, Université de Picardie, Amiens, France.

Zitieren

APA

Richard, N., & Fumery, M. (2026). Editorial: Upadacitinib in Perianal Crohn's Disease. Authors' Reply. Alimentary Pharmacology & Therapeutics, 64(4), 546-547. https://doi.org/10.1111/apt.70817

Vancouver

Richard N, Fumery M. Editorial: Upadacitinib in Perianal Crohn's Disease. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;64(4):546-547. doi:10.1111/apt.70817

BibTeX
@article{Richard2026,
  author = {Richard, Nicolas and Fumery, Mathurin},
  title = {Editorial: Upadacitinib in Perianal Crohn's Disease. Authors' Reply},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {64},
  number = {4},
  pages = {546--547},
  doi = {10.1111/apt.70817}
}
Kostenlos starten →